Episode 341: PREMIUM – Evolocumab and what it does to cardiovascular outcomes
In episode 341, James and Mike talk about the long awaited trial of evolocumab that evaluated the impact it has on cardiovascular outcomes. Certainly not a homerun – maybe a very expensive full swing bunt with an error that leads to a single.
Show notes
1) Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
2) mystudies.org
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
